Furthermore, we suggested that Tob interacts with RIPK1 and NEMO and becomes integrated into the TNFR complex I. These molecular mechanisms could be connected to the enhanced NF-κB activation in breast cancer in the absence of Tob. Here, NFKB1 is linked to breast cancer.